Frontlight ResearchEarly access
Trial site
Yekaterinburg
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Metastatic breast cancer2 trials
- Stroke2 trials
- Diabetic eye disease1 trial
- Lupus (SLE)1 trial
- Multiple sclerosis1 trial
- Psoriatic arthritis1 trial
- Sjögren's disease1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Status
- Completed5 trials
- Active, not recruiting4 trials
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Closed trials
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Completed
Completed
Completed
Completed
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
Site data: ClinicalTrials.govUpdated 12 Nov 2026